Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Down 14.8 %

Enzo Biochem stock opened at $0.33 on Friday. The firm’s 50-day simple moving average is $0.40 and its 200 day simple moving average is $0.69. Enzo Biochem has a 52 week low of $0.25 and a 52 week high of $1.28.

Enzo Biochem (NYSE:ENZ) last issued its quarterly earnings results on Monday, March 17th. The medical research company reported ($0.02) EPS for the quarter. The firm had revenue of $7.33 million for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Virtu Financial LLC purchased a new position in shares of Enzo Biochem in the 4th quarter worth about $35,000. Lepercq Multi Asset Fund acquired a new stake in Enzo Biochem during the 4th quarter worth approximately $88,000. Wittenberg Investment Management Inc. raised its holdings in Enzo Biochem by 60.1% in the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after buying an additional 70,400 shares during the period. Geode Capital Management LLC lifted its position in Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after buying an additional 11,742 shares in the last quarter. Finally, Mink Brook Asset Management LLC acquired a new stake in shares of Enzo Biochem in the fourth quarter worth $577,000. Hedge funds and other institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.